Management strategies and possible risk factors for ventricular septal defects after transcatheter aortic valve replacement: Case series from a single center and review of literature

2017 ◽  
Vol 18 (6) ◽  
pp. 462-470 ◽  
Author(s):  
M. Rizwan Sardar ◽  
Zubair A. Khan ◽  
Anu Abraham ◽  
Wajeeha Saeed ◽  
Muhammad Farhan ◽  
...  
Keyword(s):  
Risk Factors ◽  
Aortic Valve ◽  
Transcatheter Aortic Valve Replacement ◽  
Management Strategies ◽  
Case Series ◽  
Review Of Literature ◽  
Single Center ◽  
Ventricular Septal Defects ◽  
Septal Defects ◽  
Transcatheter Aortic Valve

scholarly journals Evaluation and Management of Heart Block After Transcatheter Aortic Valve Replacement

2021 ◽  
Vol 7 ◽  
Author(s):  
Anthony J Mazzella ◽  
Sameer Arora ◽  
Michael J Hendrickson ◽  
Mason Sanders ◽  
John P Vavalle ◽  
...  
Keyword(s):  
Risk Factors ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Management Strategies ◽  
Pacemaker Implantation ◽  
Operator Experience ◽  
Transcatheter Aortic Valve ◽  
Number Of Patients

Transcatheter aortic valve replacement (TAVR) has developed substantially since its inception. Improvements in valve design, valve deployment technologies, preprocedural imaging and increased operator experience have led to a gradual decline in length of hospitalisation after TAVR. Despite these advances, the need for permanent pacemaker implantation for post-TAVR high-degree atrioventricular block (HAVB) has persisted and has well-established risk factors which can be used to identify patients who are at high risk and advise them accordingly. While most HAVB occurs within 48 hours of the procedure, there is a growing number of patients developing HAVB after initial hospitalisation for TAVR due to the trend for early discharge from hospital. Several observation and management strategies have been proposed. This article reviews major known risk factors for HAVB after TAVR, discusses trends in the timing of HAVB after TAVR and reviews some management strategies for observing transient HAVB after TAVR.

scholarly journals Transcatheter aortic valve replacement same-day discharge for selected patients: a case series

2021 ◽  
Vol 5 (2) ◽  
Author(s):  
Devesh Rai ◽  
Muhammad Waqas Tahir ◽  
Medhat Chowdhury ◽  
Hammad Ali ◽  
Rupinder Buttar ◽  
...  
Keyword(s):  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Real Time ◽  
Valve Replacement ◽  
Transcatheter Aortic Valve Replacement ◽  
Case Series ◽  
Cardiac Monitoring ◽  
Atrial Pacing ◽  
Transcatheter Aortic Valve ◽  
Same Day Discharge

Abstract Background The coronavirus disease 2019 (COVID-19) pandemic has resulted in drastic changes to the practice of medicine, requiring healthcare systems to find solutions to reduce the risk of infection. Using a case series, we propose a protocol for same-day discharge (SDD) for selected patients undergoing transcatheter aortic valve replacement (TAVR) using real-time remote cardiac monitoring. Six patients with severe symptomatic aortic stenosis underwent TAVR and were discharged on the same day. Case summary Six patients with symptomatic severe native or bioprosthetic aortic valve stenosis underwent a successful transfemoral TAVR using standard procedures, including the use of rapid atrial pacing to assess the need for permanent pacemaker implantation. Following TAVR, patients were monitored on telemetry in the recovery area for 3 h, ambulated to assess vascular access stability, and discharged with real-time remote cardiac monitoring if no new conduction abnormality was observed. The patients were seen by tele-visits within 2 days and 2 weeks after discharge. Discussion Amidst the COVID-19 pandemic, SDD following successful transfemoral TAVR may be feasible for selected patients and reduce potential COVID-19 exposure.

Transcatheter Aortic Valve Replacement in Lebanon: Population and Procedural Characteristics and Long-term Outcome – A Single Center Experience

2021 ◽  
Author(s):  
Antonio H. Frangieh
Keyword(s):  
Middle East ◽  
Aortic Valve ◽  
Aortic Valve Replacement ◽  
Valve Replacement ◽  
Cardiovascular Mortality ◽  
Transcatheter Aortic Valve Replacement ◽  
Single Center ◽  
Long Term Outcome ◽  
Transcatheter Aortic Valve

Background: Transcatheter aortic valve replacement (TAVR) programs are growing in the Middle East, but data on treated patients in this region is scarce. We sought in this study to analyze the largest single-center population in Lebanon. Methods and Results: Baseline clinical, procedural characteristics as well as in-hospital and up to five years follow-up outcomes were collected and analyzed for the 141 patients (80 ± 7 years, 51.8% females) included between 2014 and 2019. All-cause mortality at 30 days found in 5 (3.5%) cases was considered as the primary endpoint while Major Adverse Cardiovascular Events at 30 days as secondary ones: cardiovascular mortality in 3 cases (2.1%), strokes in 1 case (0.7%), percutaneous coronary intervention in 3 cases (2.1%) and myocardial infarction in 3 cases (2.1%). Device success and intended prosthesis performance were achieved in 119 (84.4%) and 121 (85.8%) patients, respectively. Multivariate analysis showed that cardiovascular mortality is strongly associated with end-stage renal failure and peripheral artery disease. The dichotomization of patients into two cohorts A and B corresponding to the first and second 3 years of the TAVR time interval showed slow evolution of TAVR patients to a younger and lower risk population but maintained good results. Conclusion: TAVR in Lebanon shows satisfactory results and good long-term outcomes. Data from the regional prospective registry is needed to assess the evolution of this therapy in the middle-east region.

Sign in / Sign up

Export Citation Format

Share Document